Cargando…
Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
Gastric cancer (GC) is the 5th most common cancer and the 3rd leading cause of cancer-related death worldwide. It is of great significance to study the underlying molecular mechanism of GC, and targeting glycolysis is a good strategy to treat GC. SET domain containing 5 (SETD5) contains a catalytic...
Autores principales: | Shi, Jing, Yu, Litao, Zhu, Changhong, Zhong, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628568/ https://www.ncbi.nlm.nih.gov/pubmed/37941780 http://dx.doi.org/10.1515/biol-2022-0697 |
Ejemplares similares
-
SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
por: Huang, Jianyi, et al.
Publicado: (2022) -
Knockdown of FOXO6 Inhibits Glycolysis and Reduces Cell Resistance to Paclitaxel in HCC Cells via PI3K/Akt Signaling Pathway
por: Yu, Xixiang, et al.
Publicado: (2020) -
SETD7 regulates chondrocyte differentiation and glycolysis via the Hippo signaling pathway and HIF-1α
por: Li, Maoquan, et al.
Publicado: (2021) -
TGIF1 Knockdown Inhibits the Proliferation and Invasion of Gastric Cancer via AKT Signaling Pathway
por: Zhang, Jing, et al.
Publicado: (2021) -
Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma
por: Cheng, Xin-sheng, et al.
Publicado: (2016)